Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor

Protein Science

Volumn 8, Issue 11, 1999, Pages 2304-2311

  Sun, Jianzhong ^a   Ember, Julia A ^a   Chao, Ta Hsiang ^a   Fukuoka, Yoshihiro ^a,b   Ye, Richard D ^c   Hugli, Tony E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

G protein coupled anaphylatoxin C3a receptor; Ligand effector binding sites; Molecular modeling; Site directed mutagenesis

Indexed keywords

ANAPHYLATOXIN; ARGININE; ASPARTIC ACID; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; FLOW CYTOMETRY; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

ANIMALIA;

EID: 0032698758     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.11.2304     Document Type: Article

References (51)

1. Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C, Zeng Z, Su K, Jurewicz AJ, Hertzberg RP, et al. 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271:20231-20234.
2. Baldwin JM. 1993. The probable arrangement of the helices in G protein-couples receptors. EMBO J 12:1693-1703.
3. Caporale LH, Tippett PS, Erickson BW, Hugh TE. 1980. The active site of C3a anaphylatoxin. J Biol Chem 255:10758-10763.
4. Chao T-H, Ember JA, Wang M, Bayon Y, Hugli TE, Ye RD. 1999. Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function. J Biol Chem 274:9721-9728.
5. Chazin WJ, Hugli TE, Wright PE. 1988. 1H NMR studies of human C3a anaphylatoxin in solution: Sequential resonance assignments, secondary structure, and global fold. Biochemists 27:9139-9148.
6. Crass T, Raffetseder U, Martin U, Grove M, Klos A, Köhl J, Bautsch W. 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol 26:1944-1950.
7. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:2119-2127.
8. DeMartino JA, Konteatis ZD, Siciliano SJ, Van Riper G, Underwood DJ, Fischer PA, Springer MS. 1995. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J Biol Chem 270:15966-15969.
9. Du P, Salon JA, Tamm JA, Hou C, Cui W, Walker MW, Adham N, Dhanoa DS, Islam I, Vaysse PJJ, et al. 1997. Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Eng 10:109-117.
10. Dufau ML. 1998. The luteinizing hormone receptor. Ann Rev Physiol 60:461-496.
11. Ember JA, Hugli TE. 1997. Complement factors and their receptors. Immunopharm 38:3-15.
12. Ember JA, Jagels MA, Hugli TE. 1998. Characterization of complement anaphylatoxins and their biological responses. In: Volanakis J, Frank, M, eds. The human complement system in health and disease. New York: Marcel Dekker, Inc. pp 241-284.
13. Ember JA, Johansen NL, Hugli TE. 1991. Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry 30:3603-3612.
14. Erickson BW, Fok K-F, Khan SA, Lukas TJ, Molinar RR, Munoz H, Prystowsky MB, Unson CG, Volk-Weiss J, Hugli TE. 1981. Synthetic studies of serum complement. Proceedings of the seventh American peptide symposium. pp 525-534.
15. Fuhlbrigge RC, Fine SM, Unanue ER, Chaplin DD. 1988. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1α cDNA. Proc Natl Acad Sci USA 85:5649-5653.
16. Fukuoka Y, Ember JA, Hugli TE. 1998a. Cloning and characterization of rat C3a receptor: Differential expression of rat C3a and C5a receptors by LPS stimulation. Biochem Biophys Res Commun 242:663-668.
17. Fukuoka Y, Ember JA, Hugli TE. 1998b. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: Alternative splicing at the large extracellular loop. J Immunol 161:2977-2984.
18. Fukuoka Y, Ember JA, Hugli TE. 1999. Ligand binding sites on guinea pig C3aR: Point- and deletion mutations in the large extracellular loop and vicinity. Biochem Biophys Res Commun. Forthcoming.
19. Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP. 1998. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonyeloid cells in inflamed human central nervous system: Analysis in multiple sclerosis and bacterial meningitis. J Immunol 160:3543-3554.
20. Gether U, Kobilka BK. 1998. G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273:17979-17982.
21. Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW. 1979. Anaphylatoxin-induced histamine release with human leukocytes: Studies of C3a leukocyte binding and histamine release. J Clin Invest 64:804-811.
22. Grötzinger J, Engels M, Jacoby E, Wollmer A, Strassburger W. 1991. A model for the C5a receptor and for its interaction with the ligand. Protein Eng 4:767-771.
23. Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U Zuberbier T. 1997. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89(8):2863-2870.
24. Higuchi R, Krummel B, Saiki RK. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucl Acids Res 16:7351-7367.
25. Horn F, Vriend G. 1998. G protein-coupled receptors in silico. J Mol Med 76:464-468.
26. Horn F, Weare J, Beukers MW, Hörsch S, Bairoch A, Chen W, Edvardsen Ø, Campagne F, Vriend G. 1998. GPCRDB: An information system for G protein-coupled receptors. Nucl Acids Res 26:275-279.
27. Hsu MH, Ember JA, Wang M, Prossnitz ER, Hugli TE, Ye RD. 1997. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics 47:64-72.
28. Huber R, Scholze H, Paques EP, Deisenhofer J. 1980. Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seyler's Z Physiol Chem 361:1389-1399.
29. Hugli TE. 1975. Human anaphylatoxin (C3a) from the third component of complement. Primary structure. J Biol Chem 25:8293-8301.
30. Hugli TE. 1984. Structure and function of the anaphylatoxins. Springer Semin Immunopathol 7(2/3):193-219.
31. Hugli TE, Gerard C, Kawahara M, Scheetz IME, Barton R, Briggs S, Koppel G, Russell S. 1981. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem 41:59-66.
32. 1 receptor. TIPS 17:135-140.
33. Inoue Y, Nakamura N, Inagami T. 1997. A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens 15:703-714.
34. Jarnagin K, Bhakta S, Zuppan P, Yee C, Ho T, Phan T, Tahilramani R, Pease JH, Miller A, Freedman R. 1996. Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists. J Biol Chem 271:28277-28286.
35. Lu ZX, Fok K-F, Erickson BW, Hugh TE. 1984. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide. J Biol Chem 259:7367-7370.
36. Miettinen HM, Mills JS, Gripentrog JM, Dratz EA, Granger BL, Jesaitis AJ. 1997. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J Immnnol 159:4045-4054.
37. Mills JS, Miettinen HM, Barnidge D, Vlases MJ, Wimer-Mackin S, Dratz EA, Sunner J, Jesaitis AJ. 1998. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J Biol Chem 273:10428-1435.
38. Mollison KW, Mandecki W, Zuiderweg ERP, Fayer L, Fey TA, Krause RA, Conway RG, Miller RG, Edalji L, Shallcross MA. et al. 1989. Identification of receptor-binding residues in the inflammatory complement protein C5a site-directed mutagenesis. Proc Natl Acad Sci USA 86:292-296.
39. Monk PN, Barker MD,Partridge LJ, Pease JE. 1995. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. J Biol Chem 270:16625-16629.
40. Morgan BP, Casque P, Singhrao SK, Piddlesden SJ. 1997. The role of complement in disorders of the nervous system. Immunopharm 38:43-50.
41. Muto Y, Fukumoto Y, Arata Y. 1985. Proton nuclear magnetic resonance study of the third component of complement: Solution conformation of the carboxyl-terminal segment of C3a fragment. Biochemistry 24(23):6659-6665.
42. Peitsch MC, Herzyk P, Wells TNC, Hubhhard RE. 1996. Automated modeling of the transmembrane region of G-protein coupled receptor by Swiss-Model. Receptors Channels 4:161-164.
43. Prossnitz ER, Schreiber RE, Bokoch GM, Ye RD. 1995. Binding of low affinity N-formyl peptide receptors to G protein: Characterization of a novel inactive receptor intermediate. J Biol Chem 270:10686-10694.
44. Pulakat L, Tadessee AS, Dittus JJ, Gavini N. 1998. Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction. Regul Pept 73:51-57.
45. Quehenberger O, Pan ZK, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD. 1994. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem Biophys Res Commun 238(2):377-381.
46. Raffetseder U, Röper D, Mery L, Gietz C, Klos A, Grötzinger J, Wollmer A, Boulay F, Köhl J, Bautsch W. 1996. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor Arg206 determines high-affinity binding sites of C5a receptor. Eur J Biochem 235:82-90.
47. Regal JF. 1997. Role of the complement system in pulmonary disorders. Immunopharmacol 38:17-25.
48. Roglic A, Prossnitz ER, Cavanagh SL, Pan Z, Zou A, Ye RD. 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim Biophys Acta 1305:39-43.
49. Siciliano SJ, Rollins TE, DeMartino J, Konteatis Z, Malkowitz L, Van Riper G, Bondy S, Rosen H, Springer MS. 1994. Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci USA 91:1214-1218.
50. Tometta MA, Foley JJ, Sarau HM, Ames RS. 1997. The mouse anaphylatoxin C3a receptor: Molecular cloning, genomic organization and functional expression. J Immunol 158:5277-5282.
51. Unson CG, Erickson BW, Hugli TE. 1984. Active site of C3a anaphylatoxin: Contributions of the lipophilic and orienting residues. Biochemistry 23:585-589.